Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia

Neurosci Lett. 2003 Nov 20;351(3):173-6. doi: 10.1016/j.neulet.2003.08.008.

Abstract

The neuroprotective effect of the neurotensin analogue H-Lys-psi(CH2NH)Lys-Pro-Tyr-Ile-Leu-OH (JMV-449) was assessed in a mouse model of permanent distal middle cerebral artery occlusion. Mice were injected with 0.6 nmol JMV-449 or vehicle i.c.v. immediately after ischaemia. The core temperature declined by 6-7 degrees C after 30 min and the hypothermia persisted for 4-5 h. JMV-449 treatment was able to reduce the infarct volume significantly both at 24 h and 14 days after onset of ischaemia. No neuroprotective effect could be seen if the mice were kept normothermic after the JMV-449 treatment suggesting that the neuroprotective effect is mediated via the hypothermia.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / pathology
  • Disease Models, Animal*
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infarction, Middle Cerebral Artery / pathology
  • Male
  • Mice
  • Neuroprotective Agents / therapeutic use*
  • Neurotensin / analogs & derivatives
  • Neurotensin / therapeutic use
  • Oligopeptides / therapeutic use*

Substances

  • Neuroprotective Agents
  • Oligopeptides
  • JMV 449
  • Neurotensin